Search for a trial

Randomized, single dose, parallel group, bioequivalence study, comparing trastuzumab (Synthon BV, the Netherlands) to Herceptin® (Hoffmann-La Roche, Switzerland) infusion in healthy male volunteers following a placebo-controlled dose escalation period

MAIN OBJECTIVESDose escalation study:To establish the safe use of trastuzumab (Synthon BV, the Netherlands) in healthy volunteers at different dose levels up to 6 mg/kg.Bioequivalence study:Demonstrate bioequivalence between trastuzumab (Synthon BV…